FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Diego Vergani

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Physiology

Concepts & Ideas

Biological Markers

Procedures

Liver Transplantation

Co-author Network

Publications

TOP 3
Maria Serena Longhi; Yun Ma; Giorgina Mieli-Vergani; Marianne Samyn; Patrick Gordon; Charlotte R Grant; Diego Vergani
T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
Rodrigo Liberal; Giorgina Mieli-Vergani; Charlotte R Grant; Diego Vergani
Autoimmune hepatitis: A comprehensive review.
Diego Vergani; Giorgina Mieli-Vergani
Autoimmune manifestations in viral hepatitis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Diego Vergani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Maria Serena Longhi; Yun Ma; Giorgina Mieli-Vergani; Marianne Samyn; Patrick Gordon; Charlotte R Grant; Diego Vergani
T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
Journal of autoimmunity 2013;41():146-51.
2013: Rodrigo Liberal; Giorgina Mieli-Vergani; Charlotte R Grant; Diego Vergani
Autoimmune hepatitis: A comprehensive review.
Journal of autoimmunity 2013;41():126-39.
2013: Diego Vergani; Giorgina Mieli-Vergani
Autoimmune manifestations in viral hepatitis.
Seminars in immunopathology 2013;35(1):73-85.
2013: Tassos Grammatikopoulos; John Karani; Bernard Portmann; Diego Vergani; Yoh Zen; Francesco Cirillo; Giorgina Mieli-Vergani
Steroid-responsive autoimmune sclerosing cholangitis with liver granulocytic epithelial lesions.
Journal of pediatric gastroenterology and nutrition 2013;56(1):e3-4.
2012: Yoh Zen; Diego Vergani; Tassos Grammatikopoulos; Michael A Heneghan; Giorgina Mieli-Vergani; Bernard C Portmann
Sclerosing cholangitis with granulocytic epithelial lesion: a benign form of sclerosing cholangiopathy.
The American journal of surgical pathology 2012;36(10):1555-61.
2012: Robin Daniel Abeles; Charalambos G Antoniades; Wafa Khamri; Yun Ma; Mark McPhail; Debbie L Shawcross; David Sowter; Nikhil Vergis; Godhev K Manakkat Vijay; Julia A Wendon; Emmanuel Xystrakis; Diego Vergani
CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi) /CD16(neg) monocytes: Expansion of CD14(hi) /CD16(pos) and contraction of CD14(lo) /CD16(pos) monocytes in acute liver failure.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2012;81(10):823-34.
2012: Maria Serena Longhi; Yun Ma; Giorgina Mieli-Vergani; Diego Vergani
Regulatory T cells in autoimmune hepatitis.
Journal of hepatology 2012;57(4):932-3; author reply 933-4.
2012: Maria G Mytilinaiou; Christian Probst; Eirini I Rigopoulou; Thomas Scheper; Diego Vergani; Andrew Kenneth Burroughs; Lars Komorowski; Andreas L Koutsoumpas; Wolfgang Meyer; Daniel Abeles; DIMITRIOS BOGDANOS
Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.
Clinica chimica acta; international journal of clinical chemistry 2012;413(15-16):1211-6.
2012: Nedim Hadžić; Munther J Hussain; Nigel Brown; Corina Cotoi; Alberto Quaglia; Diego Vergani; Giorgina Mieli-Vergani
Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children.
Pediatric transplantation 2012;16(5):501-10.
2012: Rodrigo Liberal; Charlotte R Grant; Beth S Holder; Yun Ma; Giorgina Mieli-Vergani; Diego Vergani; Maria Serena Longhi
The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
Hepatology (Baltimore, Md.) 2012;56(2):677-86.
2012: Rodrigo Liberal; Diego Vergani
Effect of ethnicity on the clinical presentation and outcome of autoimmune hepatitis.
Expert review of gastroenterology & hepatology 2012;6(3):267-9.
2012: Maria Serena Longhi; Yun Ma; Giorgina Mieli-Vergani; Simon C Robson; Beth Holder; Rodrigo Liberal; Diego Vergani
Inhibition of interleukin-17 promotes differentiation of CD25⁻ cells into stable T regulatory cells in patients with autoimmune hepatitis.
Gastroenterology 2012;142(7):1526-35.e6.
2012: Diego Vergani; Giorgina Mieli-Vergani
Cutting edge issues in autoimmune hepatitis.
Clinical reviews in allergy & immunology 2012;42(3):309-21.
2012: Rodrigo Liberal; Maria Serena Longhi; Giorgina Mieli-Vergani; Charlotte R Grant; Diego Vergani
Autoimmune hepatitis after liver transplantation.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2012;10(4):346-53.
2012: Daniel Smyk; Diego Vergani; Harold Baum; Andrew Kenneth Burroughs; Eirini I Rigopoulou; DIMITRIOS BOGDANOS
Autoimmunity and environment: am I at risk?
Clinical reviews in allergy & immunology 2012;42(2):199-212.
2011: Giorgina Mieli-Vergani; Diego Vergani
Autoimmune liver diseases in children - what is different from adulthood?
Best practice & research. Clinical gastroenterology 2011;25(6):783-95.
2011: Rodrigo Liberal; Maria Serena Longhi; Giorgina Mieli-Vergani; Diego Vergani
Pathogenesis of autoimmune hepatitis.
Best practice & research. Clinical gastroenterology 2011;25(6):653-64.
2011: Giorgina Mieli-Vergani; Diego Vergani
Autoimmune hepatitis.
Nature reviews. Gastroenterology & hepatology 2011;8(6):320-9.
2011: Yan Zhao; Yonghong Zhang; Yan-min Liu; Yan Liu; Xia Feng; Hui-yu Liao; Diego Vergani; Yun Ma; Hui-ping Yan
Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto-immune hepatitis.
Liver international : official journal of the International Association for the Study of the Liver 2011;31(5):721-9.
2011: Diego Vergani; Giorgina Mieli-Vergani
Pharmacological management of autoimmune hepatitis.
Expert opinion on pharmacotherapy 2011;12(4):607-13.
2011: Ivana Carey; Lorenzo D'Antiga; Sanjay Bansal; Maria Serena Longhi; Yun Ma; Irene Rebollo Mesa; Giorgina Mieli-Vergani; Diego Vergani
Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy.
Journal of virology 2011;85(5):2416-28.
2011: Maria Serena Longhi; Munther J Hussain; William W Kwok; Giorgina Mieli-Vergani; Yun Ma; Diego Vergani
Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
Hepatology (Baltimore, Md.) 2011;53(2):536-47.
2010: Alex S Knisely; Diego Vergani
"Neonatal hemochromatosis": a re-vision.
Hepatology (Baltimore, Md.) 2010;51(6):1888-90.
2010: Philip Berry; Charalambos Gustav Antoniades; Munther J Hussain; M J W McPhail; William Bernal; Diego Vergani; Julia Wendon
Admission levels and early changes in serum interleukin-10 are predictive of poor outcome in acute liver failure and decompensated cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2010;30(5):733-40.
2010: Giorgina Mieli-Vergani; Diego Vergani
Unique features of primary sclerosing cholangitis in children.
Current opinion in gastroenterology 2010;26(3):265-8.
2010: Lucia A Possamai; Charalambos Gustav Antoniades; Quentin M Anstee; Alberto Quaglia; Diego Vergani; Mark Thursz; Julia Wendon
Role of monocytes and macrophages in experimental and human acute liver failure.
World journal of gastroenterology : WJG 2010;16(15):1811-9.
2010: Maria Serena Longhi; Yun Ma; Giorgina Mieli-Vergani; Diego Vergani
Aetiopathogenesis of autoimmune hepatitis.
Journal of autoimmunity 2010;34(1):7-14.
2010: DIMITRIOS BOGDANOS; Harold Baum; Diego Vergani; Andrew Kenneth Burroughs
The role of E. coli infection in the pathogenesis of primary biliary cirrhosis.
Disease markers 2010;29(6):301-11.
2010: Maria Serena Longhi; Yun Ma; Giorgina Mieli-Vergani; Diego Vergani
Adaptive immunity in autoimmune hepatitis.
Digestive diseases (Basel, Switzerland) 2010;28(1):63-9.
2009: Diego Vergani; Maria Serena Longhi; DIMITRIOS BOGDANOS; Yun Ma; Giorgina Mieli-Vergani
Autoimmune hepatitis.
Seminars in immunopathology 2009;31(3):421-35.
2009: Giorgina Mieli-Vergani; Diego Vergani
Biliary atresia.
Seminars in immunopathology 2009;31(3):371-81.
2009: Giorgina Mieli-Vergani; Diego Vergani
Autoimmune hepatitis in children: what is different from adult AIH?
Seminars in liver disease 2009;29(3):297-306.
2009: DIMITRIOS BOGDANOS; Giorgina Mieli-Vergani; Diego Vergani
Autoantibodies and their antigens in autoimmune hepatitis.
Seminars in liver disease 2009;29(3):241-53.
2009: Giorgina Mieli-Vergani; Solange Heller; Paloma Jara; Diego Vergani; Mei-Hwei Chang; Tomoo Fujisawa; Regino P González-Peralta; Deirdre Kelly; Neelam Mohan; Uzma Shah; Karen F Murray
Autoimmune hepatitis.
Journal of pediatric gastroenterology and nutrition 2009;49(2):158-64.
2009: Maria Serena Longhi; Ragai R Mitry; Marianne Samyn; Astrid Scalori; Munther J Hussain; Alberto Quaglia; Giorgina Mieli-Vergani; Yun Ma; Diego Vergani
Vigorous activation of monocytes in juvenile autoimmune liver disease escapes the control of regulatory T-cells.
Hepatology (Baltimore, Md.) 2009;50(1):130-42.
2009: Dimitrios P Bogdanos; Diego Vergani
Bacteria and primary biliary cirrhosis.
Clinical reviews in allergy & immunology 2009;36(1):30-9.
2008: Charalambos Gustav Antoniades; Philip Berry; Julia Wendon; Diego Vergani
The importance of immune dysfunction in determining outcome in acute liver failure.
Journal of hepatology 2008;49(5):845-61.
2008: DIMITRIOS BOGDANOS; Thomas Pusl; Christian Rust; Diego Vergani; Ulrich Beuers
Primary biliary cirrhosis following Lactobacillus vaccination for recurrent vaginitis.
Journal of hepatology 2008;49(3):466-73.
2008: DIMITRIOS BOGDANOS; Pietro Invernizzi; Ian-R Mackay; Diego Vergani
Autoimmune liver serology: current diagnostic and clinical challenges.
World journal of gastroenterology : WJG 2008;14(21):3374-87.
2008: Giorgina Mieli-Vergani; Diego Vergani
Autoimmune paediatric liver disease.
World journal of gastroenterology : WJG 2008;14(21):3360-7.
2008: Diego Vergani; Giorgina Mieli-Vergani
Aetiopathogenesis of autoimmune hepatitis.
World journal of gastroenterology : WJG 2008;14(21):3306-12.
2008: Diego Vergani; Giorgina Mieli-Vergani
Autoimmune Hepatitis and PSC Connection.
Clinics in liver disease 2008;12(1):187-202, x.
2008: Maria Serena Longhi; Francesca Meda; Pengyun Wang; Marianne Samyn; Giorgina Mieli-Vergani; Diego Vergani; Yun Ma
Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
Hepatology (Baltimore, Md.) 2008;47(2):581-91.
2008: Timothy J S Cross; Paolo Rizzi; Mary Horner; Anita Jolly; Munther J Hussain; Heather M Smith; Diego Vergani; Phillip Harrison
The increasing prevalence of hepatitis delta virus (HDV) infection in South London.
Journal of medical virology 2008;80(2):277-82.
2007: Eirini I Rigopoulou; Edward T Davies; DIMITRIOS BOGDANOS; Christos Liaskos; Maria Mytilinaiou; George K Koukoulis; Georgios N Dalekos; Diego Vergani
Antimitochondrial antibodies of immunoglobulin G3 subclass are associated with a more severe disease course in primary biliary cirrhosis.
Liver international : official journal of the International Association for the Study of the Liver 2007;27(9):1226-31.
2007: William Bernal; Yun Ma; Heather M Smith; Bernard Portmann; Julia Wendon; Diego Vergani
The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study.
Journal of hepatology 2007;47(5):664-70.
2007: Charalambos Gustav Antoniades; Philip Berry; Matthew Bruce; Timothy J S Cross; Andrew J Portal; Munther J Hussain; William Bernal; Julia Wendon; Diego Vergani
Actin-free Gc globulin: a rapidly assessed biomarker of organ dysfunction in acute liver failure and cirrhosis.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2007;13(9):1254-61.
2007: Maria Serena Longhi; Munther J Hussain; DIMITRIOS BOGDANOS; Alberto Quaglia; Giorgina Mieli-Vergani; Yun Ma; Diego Vergani
Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2.
Hepatology (Baltimore, Md.) 2007;46(2):472-84.
2007: DIMITRIOS BOGDANOS; Christos Liaskos; Albert Pares; Gary Norman; Eirini I Rigopoulou; Llorenc Caballeria; Georgios N Dalekos; Juan Rodes; Diego Vergani
Anti-gp210 antibody mirrors disease severity in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2007;45(6):1583; author reply 1583-4.
2007: Diego Vergani; Giorgina Mieli-Vergani
The impact of autoimmunity on hepatocytes.
Seminars in liver disease 2007;27(2):140-51.
2007: Eirini I Rigopoulou; DIMITRIOS BOGDANOS; Christos Liaskos; Andreas Koutsoumpas; Harold Baum; Diego Vergani; Georgios N Dalekos
Anti-mitochondrial antibody immunofluorescent titres correlate with the number and intensity of immunoblot-detected mitochondrial bands in patients with primary biliary cirrhosis.
Clinica chimica acta; international journal of clinical chemistry 2007;380(1-2):118-21.
2007: Paolo Muiesan; Diego Vergani; Giorgina Mieli-Vergani
Liver transplantation in children.
Journal of hepatology 2007;46(2):340-8.
2006: DIMITRIOS BOGDANOS; A Koutsoumpas; Harold Baum; Diego Vergani
Borrelia Burgdorferi: a new self-mimicking trigger in primary biliary cirrhosis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2006;38(10):781-2; author reply 782-3.
2006: Dimitrios Polymeros; DIMITRIOS BOGDANOS; Richard Day; Dimitryi Arioli; Diego Vergani; Alastair Forbes
Does cross-reactivity between mycobacterium avium paratuberculosis and human intestinal antigens characterize Crohn's disease?
Gastroenterology 2006;131(1):85-96.
2006: Charalambos Gustav Antoniades; Philip Berry; Edward T Davies; Munther Hussain; William Bernal; Diego Vergani; Julia Wendon
Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.
Hepatology (Baltimore, Md.) 2006;44(1):34-43.
2006: Maria Serena Longhi; Munther J Hussain; Ragai R Mitry; Sunil K Arora; Giorgina Mieli-Vergani; Diego Vergani; Yun Ma
Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(7):4484-91.
2006: Yun Ma; DIMITRIOS BOGDANOS; Munther J Hussain; James Underhill; Sanjay Bansal; Maria Serena Longhi; Paul Cheeseman; Giorgina Mieli-Vergani; Diego Vergani
Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.
Gastroenterology 2006;130(3):868-82.
2006: Lorenzo D'Antiga; Marion M Aw; Mark Atkins; Alison Moorat; Diego Vergani; Giorgina Mieli-Vergani
Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study.
The Journal of pediatrics 2006;148(2):228-233.
2005: DIMITRIOS BOGDANOS; Heather Smith; Yun Ma; Harold Baum; Giorgina Mieli-Vergani; Diego Vergani
A study of molecular mimicry and immunological cross-reactivity between hepatitis B surface antigen and myelin mimics.
Clinical & developmental immunology 2005;12(3):217-24.
2005: DIMITRIOS BOGDANOS; Harold Baum; Manabu Okamoto; Paolo Montalto; Umesh C Sharma; Eirini I Rigopoulou; Jiannis Vlachogiannakos; Yun Ma; Andrew Kenneth Burroughs; Diego Vergani
Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.
Hepatology (Baltimore, Md.) 2005;42(2):458-65.
2005: Maria Serena Longhi; Yun Ma; Ragai R Mitry; DIMITRIOS BOGDANOS; Michael A Heneghan; Paul Cheeseman; Giorgina Mieli-Vergani; Diego Vergani
Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis.
Journal of autoimmunity 2005;25(1):63-71.
2005: Eirini I Rigopoulou; Edward T Davies; Albert Pares; Kalliopi Zachou; Christos Liaskos; DIMITRIOS BOGDANOS; Juan Rodes; Georgios N Dalekos; Diego Vergani
Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.
Gut 2005;54(4):528-32.
2005: Charalambos Gustav Antoniades; Julia Wendon; Diego Vergani
Paralysed monocytes in acute on chronic liver disease.
Journal of hepatology 2005;42(2):163-5.
2005: Y Ma; Mirella Meregalli; S Hodges; N Davies; DIMITRIOS BOGDANOS; Silvia Fargion; G Fiorelli; Diego Vergani
Alcohol dehydrogenase: an autoantibody target in patients with alcoholic liver disease.
International journal of immunopathology and pharmacology 2005;18(1):173-82.
2004: Diego Vergani; Giorgina Mieli-Vergani
Mechanisms of autoimmune hepatitis.
Pediatric transplantation 2004;8(6):589-93.
2004: DIMITRIOS BOGDANOS; Harold Baum; F Gunsar; D Arioli; Dimitrios Polymeros; Yun Ma; Andrew Kenneth Burroughs; Diego Vergani
Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity.
Scandinavian journal of gastroenterology 2004;39(10):981-7.
2004: Diego Vergani; Fernando Alvarez; Francesco B Bianchi; Eduardo L R Cançado; Ian R Mackay; Michael P Manns; Mikio Nishioka; Edward Penner
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group.
Journal of hepatology 2004;41(4):677-83.
2004: Maria Serena Longhi; Yun Ma; DIMITRIOS BOGDANOS; Paul Cheeseman; Giorgina Mieli-Vergani; Diego Vergani
Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease.
Journal of hepatology 2004;41(1):31-7.
2004: Diego Vergani; Giorgina Mieli-Vergani
Autoimmune hepatitis.
Minerva gastroenterologica e dietologica 2004;50(2):113-23.
2004: Diego Vergani; Giorgina Mieli-Vergani
Autoimmune hepatitis and sclerosing cholangitis.
Autoimmunity 2004;37(4):329-32.
2004: DIMITRIOS BOGDANOS; Albert Pares; Harold Baum; Llorenc Caballeria; Eirini I Rigopoulou; Yun Ma; Andrew Kenneth Burroughs; Juan Rodes; Diego Vergani
Disease-specific cross-reactivity between mimicking peptides of heat shock protein of Mycobacterium gordonae and dominant epitope of E2 subunit of pyruvate dehydrogenase is common in Spanish but not British patients with primary biliary cirrhosis.
Journal of autoimmunity 2004;22(4):353-62.
2004: DIMITRIOS BOGDANOS; Albert Pares; Juan Rodés; Diego Vergani
Primary biliary cirrhosis specific antinuclear antibodies in patients from Spain.
The American journal of gastroenterology 2004;99(4):763-4; author reply 765.
2004: Diego Vergani; DIMITRIOS BOGDANOS; Harold Baum
Unusual suspects in primary biliary cirrhosis.
Hepatology (Baltimore, Md.) 2004;39(1):38-41.
2004: DIMITRIOS BOGDANOS; Harold Baum; Alessandro Grasso; Manabu Okamoto; Patrice Butler; Yun Ma; Eirini I Rigopoulou; Paolo Montalto; Edward T Davies; Andrew Kenneth Burroughs; Diego Vergani
Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis.
Journal of hepatology 2004;40(1):31-9.
2003: DIMITRIOS BOGDANOS; Harold Baum; P Butler; Eirini I Rigopoulou; Edward T Davies; Yun Ma; Andrew Kenneth Burroughs; Diego Vergani
Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(11):801-5.
2003: DIMITRIOS BOGDANOS; Harold Baum; Diego Vergani
Antimitochondrial and other autoantibodies.
Clinics in liver disease 2003;7(4):759-77, vi.
2003: Diego Vergani; Giorgina Mieli-Vergani
Autoimmune hepatitis.
Autoimmunity reviews 2003;2(5):241-7.
2003: GV Gregorio; Kaushik Choudhuri; Yun Ma; P Pensati; R Iorio; P Grant; J Garson; DIMITRIOS BOGDANOS; Angela Vegnente; Giorgina Mieli-Vergani; Diego Vergani
Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.
Clinical and experimental immunology 2003;133(3):404-13.
2003: Giorgina Mieli-Vergani; Diego Vergani
Autoimmune liver disease in children.
Annals of the Academy of Medicine, Singapore 2003;32(2):239-43.
2003: Nanda Kerkar; Kaushik Choudhuri; Yun Ma; Ayman Mahmoud; DIMITRIOS BOGDANOS; Luigi Muratori; Francesco Bianchi; Roger Williams; Giorgina Mieli-Vergani; Diego Vergani
Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(3):1481-9.
2002: Simon Hannam; DIMITRIOS BOGDANOS; Edward T Davies; Munther J Hussain; Bernard C Portmann; Giorgina Mieli-Vergani; Diego Vergani
Neonatal liver disease associated with placental transfer of anti-mitochondrial antibodies.
Autoimmunity 2002;35(8):545-50.
2002: Germana V Gregorio; Barbara McFarlane; Paul Bracken; Diego Vergani; Giorgina Mieli-Vergani
Organ and non-organ specific autoantibody titres and IgG levels as markers of disease activity: a longitudinal study in childhood autoimmune liver disease.
Autoimmunity 2002;35(8):515-9.
2002: Nanda Kerkar; Yun Ma; Edward T Davies; P Cheeseman; Giorgina Mieli-Vergani; Diego Vergani
Detection of liver kidney microsomal type 1 antibody using molecularly based immunoassays.
Journal of clinical pathology 2002;55(12):906-9.
2002: Diego Vergani; Kaushik Choudhuri; DIMITRIOS BOGDANOS; Giorgina Mieli-Vergani
Pathogenesis of autoimmune hepatitis.
Clinics in liver disease 2002;6(3):727-37.
2002: Diego Vergani; Giorgina Mieli-Vergani
Autoimmunity after liver transplantation.
Hepatology (Baltimore, Md.) 2002;36(2):271-6.
2002: Yun Ma; Mark Thomas; Manabu Okamoto; DIMITRIOS BOGDANOS; Sylvia Nagl; Nanda Kerkar; Agnel Ross Lopes; Luigi Muratori; Marco Lenzi; Francesco B Bianchi; Giorgina Mieli-Vergani; Diego Vergani
Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(1):277-85.
2002: Yun Ma; Manabu Okamoto; Mark Thomas; DIMITRIOS BOGDANOS; Agnel Ross Lopes; Bernard Portmann; James Underhill; Ralf Dürr; Giorgina Mieli-Vergani; Diego Vergani
Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Hepatology (Baltimore, Md.) 2002;35(3):658-64.
2002: Giorgina Mieli-Vergani; Diego Vergani
Autoimmune liver disease.
Indian journal of pediatrics 2002;69(1):93-8.
2002: DIMITRIOS BOGDANOS; Harold Baum; Umesh C Sharma; Alessandro Grasso; Yun Ma; Andrew Kenneth Burroughs; Diego Vergani
Antibodies against homologous microbial caseinolytic proteases P characterise primary biliary cirrhosis.
Journal of hepatology 2002;36(1):14-21.
2001: Yun Ma; Anna Ludovica Fracanzani; Maurizio Sampietro; Michela Mattioli; P Cheeseman; Roger Williams; Giorgina Mieli-Vergani; Diego Vergani; Silvia Fargion
Autoantibodies to human cytosol: a marker of sporadic porphyria cutanea tarda.
Clinical and experimental immunology 2001;126(1):47-53.
2001: DIMITRIOS BOGDANOS; Kaushik Choudhuri; Diego Vergani
Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences.
Liver 2001;21(4):225-32.
2001: Harold Baum; DIMITRIOS BOGDANOS; Diego Vergani
Antibodies to Clp protease in primary biliary cirrhosis: possible role of a mimicking T-cell epitope.
Journal of hepatology 2001;34(5):785-7.
2001: GV Gregorio; Bernard Portmann; John Karani; Phillip Harrison; Peter T Donaldson; Diego Vergani; Giorgina Mieli-Vergani
Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study.
Hepatology (Baltimore, Md.) 2001;33(3):544-53.
2000: George J M Webster; Stephanie Reignat; Mala K Maini; Simon A Whalley; Graham S Ogg; A King; David Brown; Peter L Amlot; Roger Williams; Diego Vergani; Geoffrey Dusheiko; Antonio Bertoletti
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms.
Hepatology (Baltimore, Md.) 2000;32(5):1117-24.
2000: DIMITRIOS BOGDANOS; G Mieli-Vergani; Diego Vergani
Virus, liver and autoimmunity.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32(5):440-6.
2000: Mala K Maini; C Boni; C K Lee; J R Larrubia; Stephanie Reignat; Graham S Ogg; Abigail S Bailey; J Herberg; Richard Gilson; Akeel Alisa; Roger Williams; Diego Vergani; Nikolai Naoumov; Carlo Ferrari; Antonio Bertoletti
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.
The Journal of experimental medicine 2000;191(8):1269-80.
2000: Diego Vergani
LKM antibody: getting in some target practice.
Gut 2000;46(4):449-50.
1999: Mala K Maini; C Boni; Graham S Ogg; Abigail S Bailey; Stephanie Reignat; C K Lee; J R Larrubia; George J M Webster; A J McMichael; Carlo Ferrari; Roger Williams; Diego Vergani; Antonio Bertoletti
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection.
Gastroenterology 1999;117(6):1386-96.
1999: Niels Ejskjaer; Sefina Arif; Wendy Dodds; Maria M Zanone; Diego Vergani; Peter J Watkins; Mark Peakman
Prevalence of autoantibodies to autonomic nervous tissue structures in Type 1 diabetes mellitus.
Diabetic medicine : a journal of the British Diabetic Association 1999;16(7):544-9.
1999: I Nagata; G Colucci; GV Gregorio; P Cheeseman; Roger Williams; Giorgina Mieli-Vergani; Diego Vergani
The role of HBV DNA quantitative PCR in monitoring the response to interferon treatment in chronic hepatitis B virus infection.
Journal of hepatology 1999;30(6):965-9.
1999: X J Xu; C Gearon; E Stevens; Diego Vergani; H Baum; Mark Peakman
Spontaneous T-cell proliferation in the non-obese diabetic mouse to a peptide from the unique class II MHC molecule, I-Ag7, which is also protective against the development of autoimmune diabetes.
Diabetologia 1999;42(5):560-5.
1999: Nanda Kerkar; Yun Ma; M Hussain; Luigi Muratori; C Targett; Roger Williams; Francesco B Bianchi; Giorgina Mieli-Vergani; Diego Vergani
A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1.
Journal of immunological methods 1999;223(2):227-35.
1999: GV Gregorio; Kaushik Choudhuri; Yun Ma; Angela Vegnente; Giorgina Mieli-Vergani; Diego Vergani
Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(3):1802-10.
1998: Kaushik Choudhuri; Diego Vergani
MHC restriction to T-cell autoaggression: an emerging understanding of IDDM pathogenesis.
Diabetes/metabolism reviews 1998;14(4):285-301.
1998: N Pelli; A H Fensom; C Slade; F Boa; Giorgina Mieli-Vergani; Diego Vergani
Argininosuccinate lyase: a new autoantigen in liver disease.
Clinical and experimental immunology 1998;114(3):455-61.
1998: Kaushik Choudhuri; GV Gregorio; Giorgina Mieli-Vergani; Diego Vergani
Immunological cross-reactivity to multiple autoantigens in patients with liver kidney microsomal type 1 autoimmune hepatitis.
Hepatology (Baltimore, Md.) 1998;28(5):1177-81.
1998: GV Gregorio; P Pensati; R Iorio; Angela Vegnente; Giorgina Mieli-Vergani; Diego Vergani
Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection.
Clinical and experimental immunology 1998;112(3):471-6.
1998: Diego Vergani; GV Gregorio; Kaushik Choudhuri; Yun Ma; Angela Vegnente; Giorgina Mieli-Vergani
Hepatitis virus induced autoimmunity.
Acta gastro-enterologica Belgica 1998;61(2):217-8.
1998: Munther J Hussain; J Maher; T Warnock; A Vats; Mark Peakman; Diego Vergani
Cytokine overproduction in healthy first degree relatives of patients with IDDM.
Diabetologia 1998;41(3):343-9.
1998: Nanda Kerkar; N Hadzić; Edward T Davies; B Portmann; Peter T Donaldson; Mohamed Rela; Nigel D Heaton; Diego Vergani; Giorgina Mieli-Vergani
De-novo autoimmune hepatitis after liver transplantation.
Lancet 1998;351(9100):409-13.
1998: Giorgina Mieli-Vergani; Diego Vergani
Immunological liver diseases in children.
Seminars in liver disease 1998;18(3):271-9.
1997: C L Gearon; Munther J Hussain; Diego Vergani; Mark Peakman
Lymphocyte vaccination protects prediabetic non-obese diabetic mice from developing diabetes mellitus.
Diabetologia 1997;40(12):1388-95.
1997: Simona Maule; Roberto Quadri; D Mirante; Riccardo Pellerito; E Marucco; Carlo Marinone; Diego Vergani; Livio Chiandussi; Maria M Zanone
Autonomic nervous dysfunction in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA): possible pathogenic role of autoantibodies to autonomic nervous structures.
Clinical and experimental immunology 1997;110(3):423-7.
1997: GV Gregorio; Bernard Portmann; A P Mowat; Diego Vergani; Giorgina Mieli-Vergani
A 12-year-old girl with antimitochondrial antibody-positive autoimmune hepatitis.
Journal of hepatology 1997;27(4):751-4.
1997: Maria M Zanone; J S Petersen; Diego Vergani; Mark Peakman
Expression of glutamic acid decarboxylase in nervous tissue structures targeted by autoantibodies in patients with diabetic autonomic neuropathy.
Journal of neuroimmunology 1997;78(1-2):1-7.
1997: M J Cachia; Mark Peakman; Maria M Zanone; Peter J Watkins; Diego Vergani
Reproducibility and persistence of neural and adrenal autoantibodies in diabetic autonomic neuropathy.
Diabetic medicine : a journal of the British Diabetic Association 1997;14(6):461-5.
1997: Yun Ma; GV Gregorio; Joop Gäken; Luigi Muratori; Francesco B Bianchi; Giorgina Mieli-Vergani; Diego Vergani
Establishment of a novel radioligand assay using eukaryotically expressed cytochrome P4502D6 for the measurement of liver kidney microsomal type 1 antibody in patients with autoimmune hepatitis and hepatitis C virus infection.
Journal of hepatology 1997;26(6):1396-402.
1997: GV Gregorio; Bernard Portmann; F Reid; Peter T Donaldson; Derek G Doherty; M McCartney; A P Mowat; Diego Vergani; Giorgina Mieli-Vergani
Autoimmune hepatitis in childhood: a 20-year experience.
Hepatology (Baltimore, Md.) 1997;25(3):541-7.
1997: Y Ma; Joop Gäken; Barbara McFarlane; YJ Foss; Farzin Farzaneh; Ian G McFarlane; Giorgina Mieli-Vergani; Diego Vergani
Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease.
Gastroenterology 1997;112(2):483-92.
1996: GV Gregorio; P Bracken; Giorgina Mieli-Vergani; Diego Vergani
Prevalence of antibodies to hepatitis C and herpes simplex virus type 1 is not increased in children with liver kidney microsomal type 1 autoimmune hepatitis.
Journal of pediatric gastroenterology and nutrition 1996;23(5):534-7.
1996: Sefina Arif; Sadeq Vallian Borujeni; F Farzaneh; Maria M Zanone; S L James; Massimo Pietropaolo; S Hettiarachchi; Diego Vergani; G S Conway; Mark Peakman
Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease.
The Journal of clinical endocrinology and metabolism 1996;81(12):4439-45.
1996: Mark Peakman; R David G Leslie; L Alviggi; Mohammed I Hawa; Diego Vergani
Persistent activation of CD8+ T-cells characterizes prediabetic twins.
Diabetes care 1996;19(11):1177-84.
1996: M Mahalingam; A Pozniak; T J McManus; G Senaldi; Diego Vergani; Mark Peakman
Abnormalities of CD45 isoform expression in HIV infection.
Clinical immunology and immunopathology 1996;81(2):210-4.
1996: GV Gregorio; H Jones; Kaushik Choudhuri; Angela Vegnente; Flavia Bortolotti; Giorgina Mieli-Vergani; Diego Vergani
Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
Hepatology (Baltimore, Md.) 1996;24(3):520-3.
1996: Diego Vergani; Giorgina Mieli-Vergani
Autoimmune hepatitis.
Annali italiani di medicina interna : organo ufficiale della Società italiana di medicina interna 1996;11(2):119-24.
1996: Munther J Hussain; Mark Peakman; H Gallati; S S Lo; Mohammed I Hawa; G C Viberti; Peter J Watkins; R David G Leslie; Diego Vergani
Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM.
Diabetologia 1996;39(1):60-9.
1996: Giorgina Mieli-Vergani; Diego Vergani
Autoimmune hepatitis.
Archives of disease in childhood 1996;74(1):2-5.
1995: M Mahalingam; A Pozniak; T J McManus; Diego Vergani; Mark Peakman
Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
Clinical and experimental immunology 1995;102(3):481-6.
1995: GV Gregorio; E T Davies; Giorgina Mieli-Vergani; Diego Vergani
Significance of extractable nuclear antigens in childhood autoimmune liver disease.
Clinical and experimental immunology 1995;102(2):308-13.
1995: G Senaldi; E T Davies; Mark Peakman; Diego Vergani; J Lu; K B Reid
Frequency of mannose-binding protein deficiency in patients with systemic lupus erythematosus.
Arthritis and rheumatism 1995;38(11):1713-4.
1995: J Ochola; M Hussain; M Khamashta; G R Hughes; Diego Vergani
Detection of brain-reactive autoantibodies in the sera of patients with systemic lupus erythematosus and cerebral involvement.
Journal of immunological methods 1995;185(2):259-61.
1995: G Senaldi; E T Davies; M Mahalingam; J Lu; A Pozniak; Mark Peakman; K B Reid; Diego Vergani
Circulating levels of mannose binding protein in human immunodeficiency virus infection.
The Journal of infection 1995;31(2):145-8.
1995: J M Porcel; J Ordi; A Castro-Salomo; Miquel Vilardell; M J Rodrigo; T Gene; F Warburton; M Kraus; Diego Vergani
The value of complement activation products in the assessment of systemic lupus erythematosus flares.
Clinical immunology and immunopathology 1995;74(3):283-8.
1995: S Han; M Tredger; GV Gregorio; Giorgina Mieli-Vergani; Diego Vergani
Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease.
Hepatology (Baltimore, Md.) 1995;21(1):58-62.
1995: Mark Peakman; M Mahalingam; A Pozniak; T J McManus; A N Phillips; Diego Vergani
Markers of immune cell activation and disease progression. Cell activation in HIV disease.
Advances in experimental medicine and biology 1995;374():17-26.
1994: Munther J Hussain; J Y Lau; Roger Williams; Diego Vergani
Hepatic expression of tumour necrosis factor-alpha in chronic hepatitis B virus infection.
Journal of clinical pathology 1994;47(12):1112-5.
1994: Munther J Hussain; A Mustafa; H Gallati; A P Mowat; Giorgina Mieli-Vergani; Diego Vergani
Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease.
Journal of hepatology 1994;21(5):816-21.
1994: Maria M Zanone; J S Petersen; Mark Peakman; C J Mathias; Peter J Watkins; T Dyrberg; Diego Vergani
High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy.
Diabetes 1994;43(9):1146-51.
1994: Giorgina Mieli-Vergani; Diego Vergani
Progress in pediatric autoimmune hepatitis.
Seminars in liver disease 1994;14(3):282-8.
1994: Yun Ma; Mark Peakman; A Lobo-Yeo; L Wen; M Lenzi; Joop Gäken; F Farzaneh; Giorgina Mieli-Vergani; Francesco B Bianchi; Diego Vergani
Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Clinical and experimental immunology 1994;97(1):94-9.
1994: R A Smerdon; Mark Peakman; Munther J Hussain; F S Wong; Peter J Watkins; R David G Leslie; Diego Vergani
CD5+ B-cells at the onset of type I diabetes and in the prediabetic period.
Diabetes care 1994;17(7):657-64.
1994: F D Mackie; Mark Peakman; M Yun; R Sallie; H Smith; E T Davies; Giorgina Mieli-Vergani; Diego Vergani
Primary and secondary liver/kidney microsomal autoantibody response following infection with hepatitis C virus.
Gastroenterology 1994;106(6):1672-5.
1994: B A Acunas; Mark Peakman; G Liossis; E T Davies; B Bakoleas; C Costalos; H R Gamsu; Diego Vergani
Effect of fresh frozen plasma and gammaglobulin on humoral immunity in neonatal sepsis.
Archives of disease in childhood. Fetal and neonatal edition 1994;70(3):F182-7.
1994: Mark Peakman; L Alviggi; Munther J Hussain; S S Lo; Mohammed I Hawa; R David G Leslie; Diego Vergani
Increased expression of T-cell markers of immunological memory associated with protection from type I diabetes. A study of identical twins.
Diabetes 1994;43(5):712-7.
1994: R Y Tun; Mark Peakman; L Alviggi; Munther J Hussain; S S Lo; M Shattock; DA Pyke; G F Bottazzo; Diego Vergani; R David G Leslie
Importance of persistent cellular and humoral immune changes before diabetes develops: prospective study of identical twins.
BMJ (Clinical research ed.) 1994;308(6936):1063-8.
1994: Mark Peakman; M Mahalingam; richard leslie; Diego Vergani
Co-expression of CD45RA (naive) and CD45R0 (memory) T-cell markers.
Lancet 1994;343(8894):424.
1994: Mark Peakman; T Warnock; A Vats; G L McNab; James Underhill; Peter T Donaldson; Diego Vergani
Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives.
Diabetologia 1994;37(2):155-65.
1994: Mark Peakman; G L McNab; N D Heaton; K C Tan; Diego Vergani
Development of techniques for obtaining monodispersed human islet cells.
Transplantation 1994;57(3):384-93.
1994: G Senaldi; Mark Peakman; C Natoli; Munther J Hussain; H Gallati; T McManus; Diego Vergani; S Iacobelli
Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus.
The Journal of infection 1994;28(1):31-9.
1994: Mark Peakman; L Wen; G L McNab; Peter J Watkins; K C Tan; Diego Vergani
T cell clones generated from patients with type 1 diabetes using interleukin-2 proliferate to human islet antigens.
Autoimmunity 1994;17(1):31-9.
1994: D G Doherty; James Underhill; Peter T Donaldson; K Manabe; Giorgina Mieli-Vergani; A L Eddleston; Diego Vergani; Andrew G Demaine; Roger Williams
Polymorphism in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis.
Autoimmunity 1994;18(4):243-9.
1993: R A Smerdon; Mark Peakman; Munther J Hussain; Diego Vergani
Lymphocyte vaccination prevents spontaneous diabetes in the non-obese diabetic mouse.
Immunology 1993;80(3):498-501.
1993: M Mahalingam; Mark Peakman; E T Davies; A Pozniak; T J McManus; Diego Vergani
T cell activation and disease severity in HIV infection.
Clinical and experimental immunology 1993;93(3):337-43.
1993: Mark Peakman; R David G Leslie; Diego Vergani
Immunological studies on type 1 diabetes in identical twins.
Archives of disease in childhood 1993;69(1):97-9.
1993: Maria M Zanone; Mark Peakman; T Purewal; Peter J Watkins; Diego Vergani
Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus.
Diabetologia 1993;36(6):564-9.
1993: Mark Peakman; J M Tredger; E T Davies; M Davenport; Bruce Dunne; Roger Williams; Diego Vergani
Analysis of peripheral blood mononuclear cells in rodents by three-colour flow cytometry using a small-volume lysed whole blood technique.
Journal of immunological methods 1993;158(1):87-94.
1993: J M Porcel; Mark Peakman; G Senaldi; Diego Vergani
Methods for assessing complement activation in the clinical immunology laboratory.
Journal of immunological methods 1993;157(1-2):1-9.
1993: R A Smerdon; Mark Peakman; Munther J Hussain; L Alviggi; Peter J Watkins; R David G Leslie; Diego Vergani
Increase in simultaneous coexpression of naive and memory lymphocyte markers at diagnosis of IDDM.
Diabetes 1993;42(1):127-33.
1992: G Senaldi; B Portmann; A P Mowat; Giorgina Mieli-Vergani; Diego Vergani
Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis.
Archives of disease in childhood 1992;67(12):1447-53.
1992: J M Porcel; Diego Vergani
Complement and lupus: old concepts and new directions.
Lupus 1992;1(6):343-9.
1992: Mark Peakman; Andrea G S Buggins; K H Nicolaides; D M Layton; Diego Vergani
Analysis of lymphocyte phenotypes in cord blood from early gestation fetuses.
Clinical and experimental immunology 1992;90(2):345-50.
1992: Mark Peakman; G Senaldi; G Liossis; H R Gamsu; Diego Vergani
Complement activation in neonatal infection.
Archives of disease in childhood 1992;67(7 Spec No):802-7.
1992: L Wen; Mark Peakman; Giorgina Mieli-Vergani; Diego Vergani
Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease.
Clinical and experimental immunology 1992;89(1):78-82.
1992: D G Doherty; R Ireland; Andrew G Demaine; F Wang; K Veerapan; K I Welsh; Diego Vergani
Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in southern Chinese.
Arthritis and rheumatism 1992;35(6):641-6.
1992: Mark Peakman; G Senaldi; N Foote; T J McManus; Diego Vergani
Naturally occurring soluble CD4 in patients with human immunodeficiency virus infection.
The Journal of infectious diseases 1992;165(5):799-804.
1991: E T Littleton; L Bevis; L J Hansen; Mark Peakman; A P Mowat; Giorgina Mieli-Vergani; Diego Vergani
Alpha 1-antitrypsin deficiency, complement activation, and chronic liver disease.
Journal of clinical pathology 1991;44(10):855-8.
1991: N Hadzic; A Alberti; B Portmann; Diego Vergani
Detection of hepatitis B virus pre-S1 and pre-S2 determinants in paraffin wax embedded liver tissue: importance of reagents used.
Journal of clinical pathology 1991;44(7):554-7.
1991: H W Jones; R Ireland; G Senaldi; F Wang; M Khamashta; A J Bellingham; K Veerapan; G R Hughes; Diego Vergani
Anticardiolipin antibodies in patients from Malaysia with systemic lupus erythematosus.
Annals of the rheumatic diseases 1991;50(3):173-5.
1991: G Senaldi; A Lobo-Yeo; A P Mowat; Giorgina Mieli-Vergani; Diego Vergani
Class I and class II major histocompatibility complex antigens on hepatocytes: importance of the method of detection and expression in histologically normal and diseased livers.
Journal of clinical pathology 1991;44(2):107-14.
1990: L Wen; Mark Peakman; A Lobo-Yeo; B M McFarlane; A P Mowat; Giorgina Mieli-Vergani; Diego Vergani
T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis.
Lancet 1990;336(8730):1527-30.
1990: G Senaldi; Mark Peakman; T McManus; E T Davies; D E Tee; Diego Vergani
Activation of the complement system in human immunodeficiency virus infection: relevance of the classical pathway to pathogenesis and disease severity.
The Journal of infectious diseases 1990;162(6):1227-32.
1990: B R Bhaduri; K C Tan; S Humphreys; Roger Williams; P Donaldson; Diego Vergani; A P Mowat; Giorgina Mieli-Vergani
Graft-versus-host disease after orthotopic liver transplantation in a child.
Transplantation proceedings 1990;22(5):2378-80.
1990: A Lobo-Yeo; G Senaldi; B Portmann; A P Mowat; Giorgina Mieli-Vergani; Diego Vergani
Class I and class II major histocompatibility complex antigen expression on hepatocytes: a study in children with liver disease.
Hepatology (Baltimore, Md.) 1990;12(2):224-32.
1990: A Lobo-Yeo; Giorgina Mieli-Vergani; A P Mowat; Diego Vergani
Soluble interleukin 2 receptors in autoimmune chronic active hepatitis.
Gut 1990;31(6):690-3.
1990: Mark Peakman; Munther J Hussain; Beverley A Millward; R David G Leslie; Diego Vergani
Effect of initiation of insulin therapy on T-lymphocyte activation in type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 1990;7(4):327-30.
1990: mahmud taher; Mark Peakman; G Senaldi; A McWhirter; C M Black; Diego Vergani
Antireticulin antibody in systemic sclerosis.
Annals of the rheumatic diseases 1990;49(3):177-80.
1989: G Senaldi; Peter T Donaldson; S Magrin; J M Farrant; Graeme J M Alexander; Diego Vergani; Roger Williams
Activation of the complement system in primary sclerosing cholangitis.
Gastroenterology 1989;97(6):1430-4.
1989: G Senaldi; S Lupoli; Diego Vergani; C M Black
Activation of the complement system in systemic sclerosis. Relationship to clinical severity.
Arthritis and rheumatism 1989;32(10):1262-7.
1989: Mark Peakman; G Senaldi; Diego Vergani
Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?
Journal of clinical pathology 1989;42(10):1018-25.
1989: G Senaldi; Mark Peakman; T McManus; E T Davies; D E Tee; Diego Vergani
Classical complement pathway in HIV infection.
Lancet 1989;2(8663):624.
1989: V A Makinde; G Senaldi; A S Jawad; H Berry; Diego Vergani
Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Annals of the rheumatic diseases 1989;48(4):302-6.
1989: A Lobo-Yeo; C McSorley; B M McFarlane; Giorgina Mieli-Vergani; A P Mowat; Diego Vergani
Detection of anti-liver cell membrane antibody using a human hepatocellular carcinoma cell line.
Hepatology (Baltimore, Md.) 1989;9(2):210-4.
1989: Giorgina Mieli-Vergani; A Lobo-Yeo; B M McFarlane; I G McFarlane; A P Mowat; Diego Vergani
Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood.
Hepatology (Baltimore, Md.) 1989;9(2):198-203.
1989: P T Donaldson; M J Hussain; G Mieli-Vergani; A P Mowat; Diego Vergani
Anti-lymphocytic antibodies in autoimmune chronic active hepatitis starting in childhood.
Clinical and experimental immunology 1989;75(1):41-6.
1989: Mark Peakman; L Bevis; Giorgina Mieli-Vergani; A P Mowat; Diego Vergani
Double stranded DNA binding in autoimmune chronic active hepatitis and primary sclerosing cholangitis starting in childhood.
Autoimmunity 1989;3(4):271-80.
1988: B G Loftus; J F Price; A Lobo-Yeo; Diego Vergani
IgG subclass deficiency in asthma.
Archives of disease in childhood 1988;63(12):1434-7.
1988: S G Gilbey; M J Hussain; Peter J Watkins; Diego Vergani
Cell-mediated immunity and symptomatic diabetic autonomic neuropathy.
Diabetic medicine : a journal of the British Diabetic Association 1988;5(9):845-8.
1988: G Senaldi; V A Makinde; Diego Vergani; D A Isenberg
Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Annals of the rheumatic diseases 1988;47(11):913-7.
1988: C Johnston; L Alviggi; Beverley A Millward; R David G Leslie; DA Pyke; Diego Vergani
Alterations in T-lymphocyte subpopulations in type I diabetes. Exploration of genetic influence in identical twins.
Diabetes 1988;37(11):1484-8.
1988: G Senaldi; Beverley A Millward; Munther J Hussain; DA Pyke; R David G Leslie; Diego Vergani
Low serum haemolytic function of the fourth complement component (C4) in insulin dependent diabetes.
Journal of clinical pathology 1988;41(10):1114-6.
1988: G Senaldi; R Ireland; A J Bellingham; Diego Vergani; K Veerapan; F Wang
IgM reduction in systemic lupus erythematosus.
Arthritis and rheumatism 1988;31(9):1213.
1988: E T Davies; B A Nasaruddin; A Alhaq; G Senaldi; Diego Vergani
Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
Journal of clinical pathology 1988;41(2):143-7.
1988: A Millward; Munther J Hussain; Mark Peakman; DA Pyke; R David G Leslie; Diego Vergani
Characterization of islet cell antibody in insulin dependent diabetes: evidence for IgG1 subclass restriction and polyclonality.
Clinical and experimental immunology 1988;71(2):353-6.
1987: Diego Vergani; Giorgina Mieli-Vergani; M Mondelli; B Portmann; A L Eddleston
Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage.
Liver 1987;7(6):307-15.
1987: Munther J Hussain; L Alviggi; Beverley A Millward; R David G Leslie; DA Pyke; Diego Vergani
Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined.
Diabetologia 1987;30(12):907-11.
1987: Mark Peakman; A Lobo-Yeo; G Senaldi; M Nilsson; D E Tee; Diego Vergani
Quantification of C3d in biological fluids by an enzyme-linked immunosorbent assay.
Journal of immunological methods 1987;104(1-2):51-6.
1987: G Senaldi; Mark Peakman; A Alhaq; V A Makinde; D E Tee; Diego Vergani
Activation of the alternative complement pathway: clinical application of a new technique to measure fragment Ba.
Journal of clinical pathology 1987;40(10):1235-9.
1987: G Senaldi; Beverley A Millward; M J Hussein; DA Pyke; R David G Leslie; Diego Vergani
Complement in type 1 (insulin-dependent) diabetes.
Diabetologia 1987;30(10):823.
1987: Mark Peakman; A Lobo-Yeo; Giorgina Mieli-Vergani; E T Davies; A P Mowat; Diego Vergani
Characterization of anti-liver kidney microsomal antibody in childhood autoimmune chronic active hepatitis: evidence for IgG1 subclass restriction, polyclonality and non cross-reactivity with hepatocyte surface antigens.
Clinical and experimental immunology 1987;69(3):543-9.
1986: S G Gilbey; R J Guy; H Jones; Diego Vergani; Peter J Watkins
Diabetes and autonomic neuropathy: an immunological association?
Diabetic medicine : a journal of the British Diabetic Association 1986;3(3):241-5.
1986: Beverley A Millward; L Alviggi; P J Hoskins; C Johnston; D Heaton; G F Bottazzo; Diego Vergani; R David G Leslie; DA Pyke
Immune changes associated with insulin dependent diabetes may remit without causing the disease: a study in identical twins.
British medical journal (Clinical research ed.) 1986;292(6523):793-6.
1986: B M McFarlane; C G McSorley; Diego Vergani; I G McFarlane; Roger Williams
Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders.
Journal of hepatology 1986;3(2):196-205.
1985: Diego Vergani; L Wells; V F Larcher; B A Nasaruddin; E T Davies; Giorgina Mieli-Vergani; A P Mowat
Genetically determined low C4: a predisposing factor to autoimmune chronic active hepatitis.
Lancet 1985;2(8450):294-8.
1984: L Alviggi; C Johnston; P J Hoskins; D E Tee; DA Pyke; R David G Leslie; Diego Vergani
Pathogenesis of insulin-dependent diabetes: a role for activated T lymphocytes.
Lancet 1984;2(8393):4-6.
1980: Diego Vergani; P Morgan-Capner; E T Davies; A W Anderson; D E Tee; J R Pattison
Joint symptoms, immune complexes, and rubella.
Lancet 1980;2(8189):321-2.